Illumina

Illumina's goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making research that was unimaginable just a few years ago possible. These studies will help advance personalized medicine. As a multinational company that values collaborative interactions, rapid delivery of solutions, and prioritizes customer needs, we are committed to addressing this challenge. Illumina’s array-based innovative solutions for DNA, RNA, and protein analysis serve as tools for disease research and drug development. The company primarily focuses on cancer, microbiology, agricultural genomics, complex diseases, and cellular and molecular biology. Clinical applications include: reproductive health, genetic and rare diseases, and oncology. Illumina's cutting-edge sequencing and array technologies are driving breakthroughs in life science research, translational and consumer genomics, as well as molecular diagnostics.